Follow up Study of Patients Having Participated in Clinical Trial 64,185-204

NCT02000830 · clinicaltrials.gov ↗

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperbilirubinemia, Neonatal

Interventions

DRUG: Stannsoporfin
DRUG: Placebo

Sponsor

InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company